A research letter in JAMA Internal Medicine discusses trends in Medicare spending for care at the end-of-life.
Read More
A study in Health Affairs looks at the potential value of one precision medicine.
Read More
Its not really shocking, but depressingly expected for drug companies to screw the public by preventing competition.
Read More
Another Milliman-related post, this time for their annual cost of health insurance report, which shows ongoing growth.
Read More
America's Health Insurance Plans release a study conducted by Milliman showing where commercial health insurance dollars go.
Read More
New "precision" medicines are being approved with fewer and small trials, which may raise safety questions.
Read More
A paper from the NBER discusses the lifetime out-of-pocket medical expenses households with persons over 70 face.
Read More
A brief from AHRQ summarizing research on mobile apps for diabetes management finds little value in improving health.
Read More
A study in Health Affairs finds small benefit from public health expenditures.
Read More
Today we look at a recent paper that once again correlates hospital market power and prices, a major cause of excessive health spending.
Read More
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.